Loading clinical trials...
Loading clinical trials...
Phase 4, Open-label, Non-randomized, Prospective Study of OZURDEX® in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study
This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Retina and Macula Specialists,Hurstville
Hurtsville, New South Wales, Australia
Retina Associates
Liverpool, New South Wales, Australia
Retina and Macula Specialists, Miranda
Miranda, New South Wales, Australia
Eye Doctors Mona Vale
Mona Vale, New South Wales, Australia
Marsden Eye Clinic
Parramatta, New South Wales, Australia
Retina & Vitreous Centre Strathfield
Strathfield, New South Wales, Australia
Strathfield Retina
Strathfield, New South Wales, Australia
Retina & Vitreous Centre City
Sydney, New South Wales, Australia
Sydney Eye and Retina Clinic
Sydney, New South Wales, Australia
Sydney Eye Hospital/Macular Diseases Centre
Sydney, New South Wales, Australia
Start Date
April 29, 2016
Primary Completion Date
October 22, 2018
Completion Date
October 22, 2018
Last Updated
January 23, 2019
202
ACTUAL participants
dexamethasone intravitreal implant
DRUG
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions